1092063-77-8

Basic information

• Product Name: N-(5-(5-fluoro-2-methoxyphenyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-8-yl)-2-(hydroxyimino)acetamide
• Synonyms: N-(5-(5-fluoro-2-methoxyphenyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-8-yl)-2-(hydroxyimino)acetamide
• CAS NO: 1092063-77-8
• Molecular Weight: 357.385
• Mol File: 1092063-77-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(5-(5-fluoro-2-methoxyphenyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-8-yl)-2-(hydroxyimino)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(5-(5-fluoro-2-methoxyphenyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-8-yl)-2-(hydroxyimino)acetamide(1092063-77-8)
• EPA Substance Registry System: N-(5-(5-fluoro-2-methoxyphenyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-8-yl)-2-(hydroxyimino)acetamide(1092063-77-8)

Safety Data

• Hazardous Substances Data: 1092063-77-8(Hazardous Substances Data)

Upstream product

• 302-17-0 chloral hydrate 
• 952598-51-5 5-(5-fluoro-2-methoxyphenyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-8-amine 
• 119-65-3 isoquinoline 
• 63927-23-1 5-bromo-8-nitroisoquinoline 
• 1092063-76-7 5-(5-fluoro-2-methoxyphenyl)-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline 
• 104737-00-0 5-bromo-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline 

Downstream Products

• 1092063-78-9 5-(5-fluoro-2-methoxyphenyl)-8-methyl-6,7,8,9-tetrahydro-1H-pyrrolo[3,2-h]isoquinoline-2,3-dione 
• 938170-27-5 5-(5-fluoro-2-methoxyphenyl)-6,7,8,9-tetrahydro-3-(hydroxyimino)-8-methyl-1H-pyrrolo[3,2-h]isoquinoline-2(3H)-one 
• 1092063-62-1 5-(5-fluoro-2-hydroxyphenyl)-3-(hydroxyimino)-8-methyl-6,7,8,9-tetrahydro-1H-pyrrolo[3,2-h]isoquinolin-2(3H)-one 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR MODULATING GATED ION CHANNELS

The present invention is directed towards radiolabeled ASIC imaging agents of formula I as well as metabolites of ASIC antagonists under formula HI wherein n can be 0 or 1 These compounds are useful for the diagnosis and treatment of diseases or disorders related to the activity of gated ion channels, namely neurological disorders, pam and inflammatory disorders